Advertisement
Screener

Citadel Advisors LLC Historic Quarter Change: USA Other Stocks, New, 2021 Q4, Page 17

CITADEL ADVISORS LLC historic quarter change: USA Other Stocks, New

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 51 quarters from 2013-06-30 to 2026-03-31, CITADEL ADVISORS LLC opened 8,173 positions, added to 6,540, reduced 6,603 and sold out of 7,821.

  • Q4 2021: Stock INTRUSION INC; Country of operation —; Class COM NEW; Shares before 0.
  • Q4 2021: Stock GT BIOPHARMA INC; Country of operation —; Class COM NEW; Shares before 0.
  • Q4 2021: Stock ACORDA THERAPEUTICS INC; Country of operation —; Class COM NEW; Shares before 0.
  • Q4 2021: Stock VOLITIONRX LTD; Country of operation United States; Class COM; Shares before 0.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1423053), 51 quarters: Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q4 2023 (2023-09-30 to 2023-12-31, filed 2024-02-14); Q3 2023 (2023-06-30 to 2023-09-30, filed 2023-11-14); Q2 2023 (2023-03-31 to 2023-06-30, filed 2023-08-14); Q1 2023 (2022-12-31 to 2023-03-31, filed 2023-05-15); Q4 2022 (2022-09-30 to 2022-12-31, filed 2023-02-14); Q3 2022 (2022-06-30 to 2022-09-30, filed 2022-11-14); Q2 2022 (2022-03-31 to 2022-06-30, filed 2022-08-15); Q1 2022 (2021-12-31 to 2022-03-31, filed 2022-05-16); Q4 2021 (2021-09-30 to 2021-12-31, filed 2022-02-14); Q3 2021 (2021-06-30 to 2021-09-30, filed 2021-11-15); Q2 2021 (2021-03-31 to 2021-06-30, filed 2021-08-16); Q1 2021 (2020-12-31 to 2021-03-31, filed 2021-05-17); Q4 2020 (2020-09-30 to 2020-12-31, filed 2021-02-16); Q3 2020 (2020-06-30 to 2020-09-30, filed 2020-11-16); Q2 2020 (2020-03-31 to 2020-06-30, filed 2020-08-14); Q1 2020 (2019-12-31 to 2020-03-31, filed 2020-05-15); Q4 2019 (2019-09-30 to 2019-12-31, filed 2020-02-14); Q3 2019 (2019-06-30 to 2019-09-30, filed 2019-11-14); Q2 2019 (2019-03-31 to 2019-06-30, filed 2019-08-14); Q1 2019 (2018-12-31 to 2019-03-31, filed 2019-05-15); Q4 2018 (2018-09-30 to 2018-12-31, filed 2019-02-14); Q3 2018 (2018-06-30 to 2018-09-30, filed 2018-11-13); Q2 2018 (2018-03-31 to 2018-06-30, filed 2018-08-10); Q1 2018 (2017-12-31 to 2018-03-31, filed 2018-05-11); Q4 2017 (2017-09-30 to 2017-12-31, filed 2018-02-09); Q3 2017 (2017-06-30 to 2017-09-30, filed 2017-11-09); Q2 2017 (2017-03-31 to 2017-06-30, filed 2017-08-11); Q1 2017 (2016-12-31 to 2017-03-31, filed 2017-05-12); Q4 2016 (2016-09-30 to 2016-12-31, filed 2017-02-10); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-13); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2009-12-31.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q4 2021INTRUSION INC
CUSIP 46121E205
—COM NEW010,260+10,260$0$35+$352022-02-14
Q4 2021GT BIOPHARMA INC
CUSIP 36254L209
—COM NEW011,442+11,442$0$35+$352022-02-14
Q4 2021ACORDA THERAPEUTICS INC
CUSIP 00484M601
—COM NEW014,455+14,455$0$35+$352022-02-14
Q4 2021VOLITIONRX LTD
CUSIP 928661107
United StatesCOM010,938+10,938$0$34+$342022-02-14
Q4 2021SCOPUS BIOPHARMA INC
CUSIP 809171101
—COM020,897+20,897$0$34+$342022-02-14
Q4 2021ARIDIS PHARMACEUTICALS INC
CUSIP 040334104
—COM014,734+14,734$0$34+$342022-02-14
Q4 2021AXCELLA HEALTH INC
CUSIP 05454B105
—COM016,341+16,341$0$34+$342022-02-14
Q4 2021ENDRA LIFE SCIENCES INC
CUSIP 29273B104
—COM049,508+49,508$0$34+$342022-02-14
Q4 2021VYNE THERAPEUTICS INC
CUSIP 92941V209
—COM032,458+32,458$0$33+$332022-02-14
Q4 2021RESEARCH FRONTIERS INC
CUSIP 760911107
United StatesCOM019,327+19,327$0$33+$332022-02-14
Q4 2021GREAT ELM CAP CORP
CUSIP 390320109
—COM010,609+10,609$0$33+$332022-02-14
Q4 2021INPIXON
CUSIP 45790J800
—COM055,619+55,619$0$33+$332022-02-14
Q4 2021HEARTBEAM INC
CUSIP 42238H108
—COM010,406+10,406$0$32+$322022-02-14
Q4 2021SUPERIOR DRILLING PRODS INC
CUSIP 868153107
—COM043,895+43,895$0$32+$322022-02-14
Q4 2021VIVEVE MED INC
CUSIP 92852W501
—COM NEW027,901+27,901$0$32+$322022-02-14
Q4 2021CLARUS THERAPEUTICS HLDNGS I
CUSIP 18271L107
—COM012,597+12,597$0$31+$312022-02-14
Q4 2021SEELOS THERAPEUTICS INC
CUSIP 81577F109
—COM018,714+18,714$0$31+$312022-02-14
Q4 2021HALL OF FAME RESORT & ENTMT
CUSIP 40619L102
—COM020,273+20,273$0$31+$312022-02-14
Q4 2021DSS INC
CUSIP 26253C102
—COM045,401+45,401$0$31+$312022-02-14
Q4 2021HYCROFT MINING HOLDING CORP
CUSIP 44862P109
—COM CL A049,292+49,292$0$30+$302022-02-14
Q4 2021SIGILON THERAPEUTICS INC
CUSIP 82657L107
—COM010,896+10,896$0$30+$302022-02-14
Q4 2021FLOTEK INDS INC DEL
CUSIP 343389102
—COM026,972+26,972$0$30+$302022-02-14
Q4 2021GAUCHO GROUP HLDGS INC
CUSIP 36809R206
—COM NEW013,567+13,567$0$29+$292022-02-14
Q4 2021PLURISTEM THERAPEUTICS INC
CUSIP 72940R300
—COM NEW019,697+19,697$0$29+$292022-02-14
Q4 2021PHIO PHARMACEUTICALS CORP
CUSIP 71880W303
—COM NEW029,097+29,097$0$29+$292022-02-14
Q4 2021CATALYST BIOSCIENCES INC
CUSIP 14888D208
—COM NEW031,516+31,516$0$29+$292022-02-14
Q4 2021SINTX TECHNOLOGIES INC
CUSIP 829392307
—COM NEW042,972+42,972$0$28+$282022-02-14
Q4 2021ECOARK HLDGS INC
CUSIP 27888N307
—COM NEW012,633+12,633$0$28+$282022-02-14
Q4 2021INFOBIRD CO LTD
CUSIP G47724102
—SHS026,056+26,056$0$28+$282022-02-14
Q4 2021AGRIFORCE GROWING SYSTEMS LT
CUSIP C00948106
—COM013,195+13,195$0$27+$272022-02-14
Q4 2021SYNLOGIC INC
CUSIP 87166L100
—COM011,293+11,293$0$27+$272022-02-14
Q4 2021CHINA NATURAL RESOURCES INC
CUSIP G2110U109
—COM045,122+45,122$0$26+$262022-02-14
Q4 2021AKUMIN INC
CUSIP 01021F109
—COM014,995+14,995$0$26+$262022-02-14
Q4 2021EMAGIN CORP
CUSIP 29076N206
—COM NEW020,480+20,480$0$26+$262022-02-14
Q4 2021DATASEA INC
CUSIP 238116206
—COM NEW015,830+15,830$0$25+$252022-02-14
Q4 2021NEW CONCEPT ENERGY INC
CUSIP 643611106
United StatesCOM010,487+10,487$0$25+$252022-02-14
Q4 2021GROM SOCIAL ENTERPRISES INC
CUSIP 39878L308
—COM NEW013,698+13,698$0$25+$252022-02-14
Q4 2021MIND TECHNOLOGY INC
CUSIP 602566101
—COM014,490+14,490$0$24+$242022-02-14
Q4 2021ORAGENICS INC
CUSIP 684023302
—COM PAR054,375+54,375$0$24+$242022-02-14
Q4 2021GENPREX INC
CUSIP 372446104
—COM017,464+17,464$0$23+$232022-02-14
Q4 2021AVENUE THERAPEUTICS INC
CUSIP 05360L205
—COM NEW024,227+24,227$0$22+$222022-02-14
Q4 2021TANTECH HLDGS LTD
CUSIP G8675X107
—COM048,875+48,875$0$22+$222022-02-14
Q4 2021US WELL SERVICES INC
CUSIP 91274U200
—CL A NEW019,546+19,546$0$22+$222022-02-14
Q4 2021ENTASIS THERAPEUTICS HLDGS I
CUSIP 293614103
—COM010,197+10,197$0$22+$222022-02-14
Q4 2021FIRST WAVE BIOPHARMA INC
CUSIP 33749P101
—COM014,101+14,101$0$20+$202022-02-14
Q4 2021CELSION CORP
CUSIP 15117N503
—COM PAR NEW033,951+33,951$0$18+$182022-02-14
Q4 2021GLOBAL INTERNET OF PEOPLE IN
CUSIP G3932F106
—SHS015,563+15,563$0$18+$182022-02-14
Q4 2021ALLENA PHARMACEUTICALS
CUSIP 018119107
—COM029,825+29,825$0$17+$172022-02-14
Q4 2021NANTHEALTH INC
CUSIP 630104107
—COM016,100+16,100$0$17+$172022-02-14
Q4 2021ROCKWELL MED INC
CUSIP 774374102
—COM040,768+40,768$0$17+$172022-02-14
Q4 2021HISTOGEN INC
CUSIP 43358Y103
—COM051,192+51,192$0$17+$172022-02-14
Q4 2021DYNATRONICS CORP
CUSIP 268157401
—COM NEW015,863+15,863$0$16+$162022-02-14
Q4 2021CLEARONE INC
CUSIP 18506U104
—COM012,716+12,716$0$16+$162022-02-14
Q4 2021ELOXX PHARMACEUTICALS INC
CUSIP 29014R103
—COM022,350+22,350$0$16+$162022-02-14
Q4 2021MARKER THERAPEUTICS INC
CUSIP 57055L107
—COM016,505+16,505$0$16+$162022-02-14
Q4 2021EVOKE PHARMA INC
CUSIP 30049G104
—COM026,592+26,592$0$15+$152022-02-14
Q4 2021ODONATE THERAPEUTICS INC
CUSIP 676079106
—COM010,397+10,397$0$14+$142022-02-14
Q4 2021SOLIGENIX INC
CUSIP 834223307
—COM021,295+21,295$0$14+$142022-02-14
Q4 2021CHECK CAP LTD
CUSIP M2361E203
—SHS020,196+20,196$0$14+$142022-02-14
Q4 2021CASI PHARMACEUTICALS INC
CUSIP 14757U109
—COM017,882+17,882$0$14+$142022-02-14
Q4 2021INMED PHARMACEUTICALS INC
CUSIP 457637502
—COM NEW011,060+11,060$0$14+$142022-02-14
Q4 2021NABRIVA THERAPEUTICS PLC
CUSIP G63637113
—SHS021,382+21,382$0$13+$132022-02-14
Q4 2021COMSOVEREIGN HLDG CORP
CUSIP 205650203
—COM NEW017,103+17,103$0$13+$132022-02-14
Q4 2021CBDMD INC
CUSIP 12482W101
—COM010,754+10,754$0$12+$122022-02-14
Q4 2021EVOFEM BIOSCIENCES INC
CUSIP 30048L104
—COM027,978+27,978$0$11+$112022-02-14
Q4 2021TYME TECHNOLOGIES INC
CUSIP 90238J103
—COM018,708+18,708$0$11+$112022-02-14
Q4 2021METACRINE INC
CUSIP 59101E103
—COM014,672+14,672$0$10+$102022-02-14
Q4 2021ITERUM THERAPEUTICS PLC
CUSIP G6333L101
—SHS022,390+22,390$0$9+$92022-02-14
Q4 2021GUARDION HEALTH SCIENCES INC
CUSIP 40145Q401
—COM010,567+10,567$0$7+$72022-02-14
Q4 2021ARYA SCIENCES ACQU CORP IV
CUSIP G31659108
—CL A0694+694$0$7+$72022-02-14
Q4 2021GOLDEN MINERALS CO
CUSIP 381119106
—COM014,855+14,855$0$5+$52022-02-14
Q4 2021GREAT PANTHER MNG LTD
CUSIP 39115V101
—COM018,694+18,694$0$4+$42022-02-14
Q4 2021TANZANIAN GOLD CORP
CUSIP 87601A107
—COM010,793+10,793$0$4+$42022-02-14

Similar Firms

Firm NameCountry13F ValueHoldings
Capital Research Global InvestorsUnited States$644.560B459
Invesco Ltd.United States$653.294B23,552
CHARLES SCHWAB INVESTMENT MANAGEMENT INCUnited States$654.473B3,645
UBS Group AGSwitzerland$666.317B22,771
ROYAL BANK OF CANADACanada$570.144B25,608
Bank of New York Mellon CorpUnited States$543.906B33,728
WELLINGTON MANAGEMENT GROUP LLPUnited States$535.463B7,458
WELLS FARGO & COMPANY/MNUnited States$530.336B17,971
Capital World InvestorsUnited States$732.940B620
DIMENSIONAL FUND ADVISORS LPUnited States$481.393B13,635